annual cash & cash equivalents:
$104.71M-$5.93M(-5.36%)Summary
- As of today (May 29, 2025), BCRX annual cash & cash equivalents is $104.71 million, with the most recent change of -$5.93 million (-5.36%) on December 31, 2024.
- During the last 3 years, BCRX annual cash & cash equivalents has fallen by -$399.68 million (-79.24%).
- BCRX annual cash & cash equivalents is now -79.24% below its all-time high of $504.39 million, reached on December 31, 2021.
Performance
BCRX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$105.19M+$477.00K(+0.46%)Summary
- As of today (May 29, 2025), BCRX quarterly cash & cash equivalents is $105.19 million, with the most recent change of +$477.00 thousand (+0.46%) on March 31, 2025.
- Over the past year, BCRX quarterly cash & cash equivalents has increased by +$20.86 million (+24.73%).
- BCRX quarterly cash & cash equivalents is now -79.15% below its all-time high of $504.39 million, reached on December 31, 2021.
Performance
BCRX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BCRX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.4% | +24.7% |
| 3 y3 years | -79.2% | -73.4% |
| 5 y5 years | -8.3% | +3.3% |
BCRX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.2% | at low | -73.4% | +34.1% |
| 5 y | 5-year | -79.2% | at low | -79.2% | +34.1% |
| alltime | all time | -79.2% | +3778.3% | -79.2% | +5743.9% |
BCRX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $105.19M(+0.5%) |
| Dec 2024 | $104.71M(-5.4%) | $104.71M(+8.1%) |
| Sep 2024 | - | $96.84M(+23.5%) |
| Jun 2024 | - | $78.41M(-7.0%) |
| Mar 2024 | - | $84.33M(-23.8%) |
| Dec 2023 | $110.64M(-63.7%) | $110.64M(-26.7%) |
| Sep 2023 | - | $150.91M(+3.2%) |
| Jun 2023 | - | $146.22M(-5.8%) |
| Mar 2023 | - | $155.14M(-49.1%) |
| Dec 2022 | $304.77M(-39.6%) | $304.77M(+23.4%) |
| Sep 2022 | - | $246.90M(-9.4%) |
| Jun 2022 | - | $272.57M(-31.1%) |
| Mar 2022 | - | $395.50M(-21.6%) |
| Dec 2021 | $504.39M(+85.4%) | $504.39M(+152.7%) |
| Sep 2021 | - | $199.60M(-5.1%) |
| Jun 2021 | - | $210.31M(-7.3%) |
| Mar 2021 | - | $226.90M(-16.6%) |
| Dec 2020 | $272.13M(+138.3%) | $272.13M(+182.0%) |
| Sep 2020 | - | $96.49M(-44.4%) |
| Jun 2020 | - | $173.47M(+70.3%) |
| Mar 2020 | - | $101.87M(-10.8%) |
| Dec 2019 | $114.17M(+327.1%) | $114.17M(+281.8%) |
| Sep 2019 | - | $29.90M(-2.8%) |
| Jun 2019 | - | $30.76M(-11.6%) |
| Mar 2019 | - | $34.80M(+30.2%) |
| Dec 2018 | $26.73M(-46.8%) | $26.73M(-49.2%) |
| Sep 2018 | - | $52.58M(+94.0%) |
| Jun 2018 | - | $27.10M(-38.1%) |
| Mar 2018 | - | $43.77M(-13.0%) |
| Dec 2017 | $50.28M(+127.5%) | $50.28M(-57.3%) |
| Sep 2017 | - | $117.78M(+196.7%) |
| Jun 2017 | - | $39.70M(-47.2%) |
| Mar 2017 | - | $75.16M(+240.0%) |
| Dec 2016 | $22.10M(-23.5%) | $22.10M(-37.5%) |
| Sep 2016 | - | $35.39M(+308.6%) |
| Jun 2016 | - | $8.66M(-32.9%) |
| Mar 2016 | - | $12.90M(-55.4%) |
| Dec 2015 | $28.90M(-47.0%) | $28.90M(-38.0%) |
| Sep 2015 | - | $46.63M(-39.3%) |
| Jun 2015 | - | $76.78M(+58.7%) |
| Mar 2015 | - | $48.37M(-11.3%) |
| Dec 2014 | $54.54M(+157.7%) | $54.54M(-55.0%) |
| Sep 2014 | - | $121.16M(-0.3%) |
| Jun 2014 | - | $121.52M(+794.6%) |
| Mar 2014 | - | $13.58M(-35.8%) |
| Dec 2013 | $21.16M(+1.3%) | $21.16M(-18.8%) |
| Sep 2013 | - | $26.05M(+31.8%) |
| Jun 2013 | - | $19.77M(+33.5%) |
| Mar 2013 | - | $14.80M(-29.1%) |
| Dec 2012 | $20.89M(+27.0%) | $20.89M(-12.8%) |
| Sep 2012 | - | $23.96M(+9.3%) |
| Jun 2012 | - | $21.92M(-20.7%) |
| Mar 2012 | - | $27.66M(+68.2%) |
| Dec 2011 | $16.44M(+20.7%) | $16.44M(-26.7%) |
| Sep 2011 | - | $22.44M(+31.9%) |
| Jun 2011 | - | $17.01M(-45.7%) |
| Mar 2011 | - | $31.34M(+130.1%) |
| Dec 2010 | $13.62M(-66.9%) | $13.62M(+21.9%) |
| Sep 2010 | - | $11.17M(-20.3%) |
| Jun 2010 | - | $14.02M(-29.5%) |
| Mar 2010 | - | $19.88M(-51.7%) |
| Dec 2009 | $41.12M | $41.12M(+125.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $18.23M(+32.0%) |
| Jun 2009 | - | $13.81M(-15.3%) |
| Mar 2009 | - | $16.30M(-27.0%) |
| Dec 2008 | $22.34M(-28.3%) | $22.34M(+40.1%) |
| Sep 2008 | - | $15.95M(-36.5%) |
| Jun 2008 | - | $25.14M(-9.8%) |
| Mar 2008 | - | $27.88M(-10.5%) |
| Dec 2007 | $31.16M(+605.3%) | $31.16M(-29.3%) |
| Sep 2007 | - | $44.09M(+514.3%) |
| Jun 2007 | - | $7.18M(-22.0%) |
| Mar 2007 | - | $9.21M(+108.4%) |
| Dec 2006 | $4.42M(-84.8%) | $4.42M(-42.9%) |
| Sep 2006 | - | $7.73M(-69.1%) |
| Jun 2006 | - | $25.05M(-41.8%) |
| Mar 2006 | - | $43.02M(+47.5%) |
| Dec 2005 | $29.16M(+229.9%) | $29.16M(+220.5%) |
| Sep 2005 | - | $9.10M(-1.5%) |
| Jun 2005 | - | $9.24M(-58.1%) |
| Mar 2005 | - | $22.05M(+149.5%) |
| Dec 2004 | $8.84M(+5.9%) | $8.84M(-36.0%) |
| Sep 2004 | - | $13.81M(-19.0%) |
| Jun 2004 | - | $17.05M(-19.1%) |
| Mar 2004 | - | $21.06M(+152.3%) |
| Dec 2003 | $8.35M(-39.6%) | $8.35M(-22.9%) |
| Sep 2003 | - | $10.83M(-22.4%) |
| Jun 2003 | - | $13.95M(+20.0%) |
| Mar 2003 | - | $11.63M(-15.9%) |
| Dec 2002 | $13.82M(-26.7%) | $13.82M(+2.1%) |
| Sep 2002 | - | $13.54M(-8.7%) |
| Jun 2002 | - | $14.83M(-20.4%) |
| Mar 2002 | - | $18.64M(-1.2%) |
| Dec 2001 | $18.87M(+123.1%) | $18.87M(-2.8%) |
| Sep 2001 | - | $19.40M(+8.0%) |
| Jun 2001 | - | $17.96M(+8.2%) |
| Mar 2001 | - | $16.61M(+96.4%) |
| Dec 2000 | $8.46M(-1.7%) | $8.46M(-3.6%) |
| Sep 2000 | - | $8.77M(-3.3%) |
| Jun 2000 | - | $9.07M(-7.3%) |
| Mar 2000 | - | $9.79M(+13.8%) |
| Dec 1999 | $8.60M(-30.1%) | $8.60M(+38.7%) |
| Sep 1999 | - | $6.20M(+17.0%) |
| Jun 1999 | - | $5.30M(-35.4%) |
| Mar 1999 | - | $8.20M(-33.3%) |
| Dec 1998 | $12.30M(+223.7%) | $12.30M(+151.0%) |
| Sep 1998 | - | $4.90M(+32.4%) |
| Jun 1998 | - | $3.70M(+5.7%) |
| Mar 1998 | - | $3.50M(-7.9%) |
| Dec 1997 | $3.80M(+5.6%) | $3.80M(-32.1%) |
| Sep 1997 | - | $5.60M(+19.1%) |
| Jun 1997 | - | $4.70M(+38.2%) |
| Mar 1997 | - | $3.40M(-5.6%) |
| Dec 1996 | $3.60M(-41.0%) | $3.60M(-44.6%) |
| Sep 1996 | - | $6.50M(+3.2%) |
| Jun 1996 | - | $6.30M(-34.4%) |
| Mar 1996 | - | $9.60M(+57.4%) |
| Dec 1995 | $6.10M(+125.9%) | $6.10M(-53.1%) |
| Sep 1995 | - | $13.00M(-10.3%) |
| Jun 1995 | - | $14.50M(+705.6%) |
| Mar 1995 | - | $1.80M(-33.3%) |
| Dec 1994 | $2.70M | $2.70M(-42.6%) |
| Sep 1994 | - | $4.70M(+46.9%) |
| Jun 1994 | - | $3.20M(-52.2%) |
| Mar 1994 | - | $6.70M |
FAQ
- What is BioCryst Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is BioCryst Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is BioCryst Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of BCRX is $104.71M
What is the all time high annual cash & cash equivalents for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual cash & cash equivalents is $504.39M
What is BioCryst Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, BCRX annual cash & cash equivalents has changed by -$5.93M (-5.36%)
What is BioCryst Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BCRX is $105.19M
What is the all time high quarterly cash & cash equivalents for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly cash & cash equivalents is $504.39M
What is BioCryst Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, BCRX quarterly cash & cash equivalents has changed by +$20.86M (+24.73%)